Therapy with 90Y-microspheres is emerging as a mainstream treatment modality in the
management of patients with primary and metastatic liver cancer (1, 2). The technique involves …

Background Treatment records and follow-up data on 40 patients with primary and
metastatic liver malignancies who underwent a single whole-liver treatment with Y-90 resin …

Scattered neutron dose equivalent to a representative point for a fetus is evaluated in an
anthropomorphic phantom of the mother undergoing proton radiotherapy. The effect on …

Background Accurate determination of the extrahepatic extent and intrahepatic distribution
of disease is very important in patients with primary and metastatic liver disease for deciding …

The clinical application of radiomicrosphere therapy (RMT) using yttrium 90 ( 90 Y) microspheres
is steadily expanding. Nuclear medicine has a paramount role in the refinement of the …

Background: Pancreatic cancer remains a disease with a poor prognosis. Historically, response
rates to chemotherapy alone remain low, and response duration lasts only months, with …

1812 Objectives: To evaluate the correlations of absorbed dose estimates to liver toxicity
and tumor response in patients with liver malignancies who underwent hepatic arterial Y-90 …

408 Objectives: To determine the relative efficacy of 90 Y radiomicrosphere therapy (RMT)
plus standard chemotherapy (chemo-RMT) compared to chemotherapy alone in patients with …

1676 Objectives: To evaluate the biologic (anatomic and physiologic) determinants of
absorbed dose estimates, and the dose response of tumor and liver toxicity in patients with liver …

Background: Positron emission tomography-computed tomography (PET-CT) has proven to
be an invaluable tool for disease assessment in oncology. The tumor standard uptake value (…